Dosage and administration subtopic
| |
Articles
1-102 out of 102 article(s)
| Title |
Author |
Type |
Date |
Words |
| Scientists in North saving young lives; Cancer drug dosages raised after research. |
|
|
Jan 17, 2013 |
728 |
| The down side of cancer salves. |
|
Brief article |
Oct 1, 2012 |
230 |
| High-Dose Vitamin C Reduces Inflammation in Cancer Patients Study Shows. |
|
|
Sep 25, 2012 |
620 |
| New immune-based cancer therapies. |
Klotter, Jule |
|
Aug 1, 2012 |
575 |
| Alternative therapeutic approach to various cancers with combinations of chemotherapeutic drugs or vitamin C and D-fraction. |
Konno, Sensuke; Alexander, Bobby; Choudhury, Muhammad |
Clinical report |
Aug 1, 2012 |
2013 |
| War on cancer. |
Moss, Ralph |
|
Apr 1, 2012 |
2170 |
| New set of nanoparticles 'may accurately deliver cancer drugs to tumours'. |
|
|
Jan 20, 2012 |
481 |
| War on Cancer: progress against chronic lymphocytic leukemia. |
Moss, Ralph |
|
Nov 1, 2011 |
2205 |
| Recommendations for the management of adult chronic myeloid leukaemia in South Africa. |
Louw, V.J.; Dreosti, L.; Ruff, P.; Jogessar, V.; Moodley, D.; Novitzky, N.; Patel, M.; Schmidt, A.; |
Disease/Disorder overview |
Nov 1, 2011 |
4783 |
| War on cancer: two new drugs emerge for melanoma. |
Moss, Ralph |
|
Oct 1, 2011 |
2311 |
| Fast-track drugs. |
Klotter, Jule |
|
Aug 1, 2011 |
683 |
| Post-chemo brain. |
Klotter, Jule |
|
Aug 1, 2011 |
460 |
| Curcumin compound boosts head and neck cancer therapy. |
Dye, D. |
Brief article |
Aug 1, 2011 |
199 |
| Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids. |
Salminen, Kaisa A.; Meyer, Achim; Jerabkova, Lenka; Korhonen, Laura E.; Rahnasto, Minna; Juvonen, Ri |
Report |
Apr 15, 2011 |
4961 |
| The case of the uncontrolled nausea and vomiting. |
Eisenberg, Seth |
|
Apr 1, 2011 |
308 |
| Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera (rituximab). |
|
|
Feb 16, 2011 |
1233 |
| Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. |
Chanmahasathien, Wisinee; Ampasavate, Chadarat; Greger, Harald; Limtrakul, Pornngarm |
Report |
Jan 15, 2011 |
5854 |
| Crizotinib shows promise against some types of NSCLC. |
McBride, Deborah |
Brief article |
Jan 1, 2011 |
270 |
| ZEVALIN Demonstrates 35-Month Progression-Free Survival Benefit after Single Dose in Patients with Non-Hodgkin's Lymphoma. |
|
|
Dec 6, 2010 |
2200 |
| Single Dose ZEVALIN in First-Ever Phase 2 Monotherapy Trial for Non-Hodgkin's Lymphoma Shows Significant and Durable Clinical Responses. |
|
|
Dec 6, 2010 |
1434 |
| Recent developments in the early diagnosis and management of multiple sclerosis. |
Ross, Amy Perrin; Thrower, Ben W. |
Report |
Dec 1, 2010 |
8621 |
| FDA delay of one drug causes 82,000 lost life-years. |
Faloon, William |
|
Nov 1, 2010 |
3988 |
| Journal abstracts: metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. |
|
|
Nov 1, 2010 |
311 |
| Bar raised in metastatic prostate Ca treatment. |
Freeman, Sara |
|
Nov 1, 2010 |
898 |
| New discipline of 'cardioncology' evolves to deal with AEs of cancer drugs. |
|
|
Oct 19, 2010 |
1045 |
| In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity. |
Huang, X.H.; Xiong, P.C.; Xiong, C.M.; Cai, Y.L.; Wei, A.H.; Wang, J.P.; Liang, X.F.; Ruan, J.L. |
Report |
Oct 1, 2010 |
5245 |
| New foe for advanced melanoma: drug offers hope to half of patients with deadly skin cancer. |
Seppa, Nathan |
Brief article |
Sep 25, 2010 |
306 |
| Agents show promise for basal cell carcinoma. |
Boschert, Sherry |
|
Sep 15, 2010 |
588 |
| FDA Approves New Dosing for FASLODEX (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women. |
|
|
Sep 10, 2010 |
1254 |
| Cellular assassin's surprise benefit; disabling killer protein might encourage repeated cancers. |
Saey, Tina Hesman |
|
Aug 28, 2010 |
455 |
| FDA Approves New Taxotere (docetaxel) Injection Concentrate Formulation. |
|
|
Aug 5, 2010 |
2190 |
| Jury hears of inmate's final hours; WARDER TELLS HOW PRISONER FEARED HE'D BEEN GIVEN WRONG DOSAGE. |
|
|
Jul 15, 2010 |
492 |
| Man's horror end after cancer drug prescription error; PRISONER GIVEN WRONG DOSAGE OF POWERFUL CHEMOTHERAPY. |
|
|
Jul 14, 2010 |
918 |
| B.C. inorganic chemists meet in Squamish. |
Leznoff, Daniel |
|
Jul 1, 2010 |
302 |
| Takeda revises Velcade starting dose for patients with hepatic impairment. |
|
Brief article |
Feb 9, 2010 |
153 |
| FDA Approves Addition of Sustained Overall Survival Benefit to Label for VELCADE[R] (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma. |
|
|
Jan 4, 2010 |
1819 |
| Good leukemia drug news. |
Seppa, Nathan |
Brief article |
Jan 2, 2010 |
106 |
| Core cancer drug scrutinized. |
|
|
Dec 22, 2009 |
418 |
| Neuroblastoma, a childhood nerve cancer, proves sensitive to drug: compound allows body's own tumor suppressor to do its job. |
Seppa, Nathan |
|
Dec 5, 2009 |
374 |
| Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors. |
Coetzee, Marius J.; Louw, Vernon J.; Gartrell, Kevin; Viljoen, Chris D. |
Report |
Dec 1, 2009 |
1441 |
| Rituxan linked to another case of PML. |
|
Brief article |
Oct 27, 2009 |
121 |
| Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin[R]. |
|
|
Oct 22, 2009 |
907 |
| Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. |
Guillen, Ponce; Carrato, Alfredo |
Clinical report |
Oct 1, 2009 |
1431 |
| Drugs reduce risk of breast cancer but increase risk of adverse effects, AHRQ says. |
|
|
Sep 30, 2009 |
710 |
| Women with breast cancer lived significantly longer without their disease getting worse when treated with Germany's Bayer AG and Onyx Pharmaceuticals Inc's (Emeryville CA) cancer pill Nexavar, researchers said. |
|
Brief article |
Sep 28, 2009 |
249 |
| Cancer drugs could help alcoholics. |
|
Brief article |
Jul 1, 2009 |
213 |
| Few cancer breakthroughs reported at major meeting. |
|
|
Jun 8, 2009 |
331 |
| Britain's healthcare cost-effectiveness watchdog has recommended Merck KGaA's drug Erbitux be used on the state health service for treating some colon cancer patients after surgery. |
|
Brief article |
Jun 8, 2009 |
219 |
| Cytotoxic therapies to feel the sting of generics: cytotoxic therapy, or chemotherapy as it is commonly known, has been the cornerstone of cancer treatment for many years and involves the use of drugs that are toxic to all cells--including those that are perfectly healthy. While relatively effective, this leads to the unpleasant side-effects commonly associated with cytotoxic treatment, such as vomiting, nausea, alopecia and fatigue. |
Dick, Matthew |
|
Mar 1, 2009 |
790 |
| Smart pumps help limit infusion errors. |
Eisenberg, Seth |
Brief article |
Mar 1, 2009 |
279 |
| 3-Hydrogenkwadaphnine, a novel diterpene ester from Dendrostellera lessertii, its role in differentiation and apoptosis of KG1 cells. |
Yazdanparast, Razieh; Meshkini, Azadeh |
Report |
Mar 1, 2009 |
4066 |
| New cytotoxic drug guidelines. |
|
Brief article |
Nov 1, 2008 |
126 |
| Treatment of gastro-oesophageal cancers: the need for international co-operation. |
Wong, Rachel; Cunningham, David |
Editorial |
Sep 1, 2008 |
1016 |
| Why do nurses resist safe-handling behaviors? |
Wujcik, Debra M. |
Editorial |
Aug 1, 2008 |
472 |
| Presidential campaign plans for universal health insurance: what they should cover--and won't Part 2. |
Cohen, Marcus A. |
|
Jul 1, 2008 |
3426 |
| Roche Holding AG, the world's biggest maker of tumor drugs, said a late-stage study showed its Herceptin medicine helped slow the spread of breast cancer when combined with its chemotherapy treatment Xeloda. |
|
Brief article |
Jun 9, 2008 |
186 |
| Targeted therapies in breast cancer. |
Peck, Rahul; Kularatne, Bihani; O'Brien, Ciara |
Report |
Jun 1, 2008 |
3839 |
| Study clarifies role of antioxidants during radiation. |
Moss, Ralph W. |
|
May 1, 2008 |
2316 |
| Drugs to treat age-related macular degeneration compared in trial. |
|
|
Mar 1, 2008 |
348 |
| Prognostic and predictive molecular markers in colorectal cancer: inhibition of the epidermal growth factor receptor. |
Stohlmacher, Jan |
|
Mar 1, 2008 |
2117 |
| Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma: a randomized phase III trial. |
Rougier, Philippe |
|
Mar 1, 2008 |
1352 |
| 21-gene assay predicts recurrence in node-positive breast Ca. |
Sullivan, Michele G. |
|
Feb 1, 2008 |
622 |
| Novel anticancer agents have autoimmune toxicities. |
Jancin, Bruce |
|
Feb 1, 2008 |
563 |
| APP Pharmaceuticals Launches Granisetron Hydrochloride Injection, USP. |
|
|
Jan 17, 2008 |
467 |
| Xanthus Receives Orphan Drug Designation for Oral Fludarabine for the Treatment of CLL. |
|
|
Jan 3, 2008 |
611 |
| No new patients for Merck, Vertex trials. |
|
Brief article |
Dec 3, 2007 |
145 |
| How much abuse should cancer patients have to take? |
Faloon, William |
|
Nov 1, 2007 |
5131 |
| Novel cancer drug shows promise. |
Kiefer, Dale |
Brief article |
Oct 1, 2007 |
160 |
| Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer. |
Carrato, Alfredo; Guillen-Ponce, Carmen |
|
Sep 1, 2007 |
1374 |
| Genotype-specific dosing may improve tolerance and anticancer activity. |
McBride, Deborah |
Brief article |
Sep 1, 2007 |
307 |
| Targeted therapy for renal cell carcinoma: a new treatment paradigm. |
Hutson, Thomas E. |
Clinical report |
Jul 1, 2007 |
4954 |
| Straight to the tumour. |
|
Reprint |
Jul 1, 2007 |
185 |
| New Clinical Data on Oral Cancer Drug REVLIMID Presented at Two Major International Medical Meetings Reports Shift in Treatment Paradigm for Treating Patients Across All Ages and Stages of Multiple Myeloma. |
|
|
Jun 7, 2007 |
569 |
| HER2-directed therapies. |
Crabb, Simon J.; Chia, Stephen K. |
|
Jun 1, 2007 |
6544 |
| Angiogenesis and breast cancer. |
Gillmore, Roopinder; Miles, David |
|
Jun 1, 2007 |
2456 |
| Conventional treatments: chemotherapy--a medical 'solution'. |
Bridgman, Karen E. |
|
Mar 22, 2007 |
5475 |
| Inhibitory effect of pirfenidone on glioblastoma cell lines: implications for treatment of neurofibromatosis. |
Krishnan, Sunil; Goble, Jennie M.; Frederick, Lori A.; James, C. David; Uhm, Joon H.; Kaufmann, Scot |
Clinical report |
Mar 1, 2007 |
4297 |
| Genentech Inc's. |
|
Brief article |
Feb 26, 2007 |
156 |
| Effects of Hydrocotyle sibthorpioides extract on transplanted tumors and immune function in mice. |
Yu, Farong; Yu, Fahong; McGuire, P.M.; Li, R.; Wang, R. |
Clinical report |
Feb 1, 2007 |
4012 |
| Drug-drug interactions in oncology: implications for general practice. |
|
Clinical report |
Feb 1, 2007 |
2090 |
| MGI PHARMA Announces Publication of Phase 2 Data Describing Dacogen(TM) (Decitabine) for Injection in Blood. |
|
|
Jan 3, 2007 |
1343 |
| Talactoferrin Alpha receives fast-track designation for the treatment of non-small cell lung cancer. |
McBride, Deborah |
|
Jan 1, 2007 |
603 |
| Bacteria-based immune therapy targets liver metastases. |
|
Brief article |
Jan 1, 2007 |
255 |
| IND for MDX-1401. |
|
Brief article |
Jan 1, 2007 |
170 |
| Temsirolimus extends survival in renal cancer. |
Lowry, Fran |
|
Oct 15, 2006 |
376 |
| High-dose tretinoin safe for skin ca prevention: irritation caused by the higher dose is usually mild and transient. |
Goldman, Erik |
Drug overview |
Jul 15, 2006 |
628 |
| Cyclacel Begins Phase I Pharmacologic Study of Oral Sapacitabine in Patients with Advanced Leukemias. |
|
|
Jun 15, 2006 |
820 |
| Callisto Receives Approvals from Three Clinical Research Sites to Advance Clinical Trial of Atiprimod; Institutional Review Board Approvals Enable Study of Anti-Cancer Drug Candidate at Higher Dosage Levels. |
|
|
Apr 12, 2006 |
723 |
| Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia. |
Oo, Thein H. |
|
Dec 1, 2005 |
773 |
| Phase I Study of High Dose Weekly ABRAXANE(TM) Published in Journal of Clinical Oncology: Responses Achieved in Patients With Taxol(R) Refractory Ovarian Cancer and Lung Cancer. |
|
|
Nov 1, 2005 |
1171 |
| Circulating tumor cells predict outcome in metastatic breast Ca. |
|
|
Apr 1, 2005 |
450 |
| New Rx for chemotherapy-induced oral mucositis. |
Jancin, Bruce |
|
Apr 1, 2005 |
613 |
| Safer way to curb local breast Ca recurrences. |
Jancin, Bruce |
|
Mar 15, 2005 |
595 |
| Breast cancer surgery seems unaffected by menstrual timing. |
|
|
Mar 15, 2005 |
337 |
| Rash often seen with new class of cancer drugs. |
Kirn, Timothy F. |
|
Mar 1, 2005 |
694 |
| Low calcium, vitamin D intake rampant in breast cancer patients. |
|
|
Mar 1, 2005 |
498 |
| Refined chemo helps in ER-negative breast Ca. |
Jancin, Bruce |
|
Mar 1, 2005 |
584 |
| Oral glutamine curbs radiation dermatitis in breast cancer patients. |
|
|
Mar 1, 2005 |
628 |
| Adjunctive chemotherapy adds benefit to tamoxifen in node-positive breast Ca. |
|
|
Mar 1, 2005 |
298 |
| A chord-based method for computing alpha particle doses to the skeleton. |
Frederick, Steven; Jokisch, Derek W. |
|
Jan 1, 2005 |
138 |
| Erlotinib, gefitinib nip lung cancer mortality. |
Goldman, Erik L. |
|
Sep 1, 2004 |
578 |
| Fighting cancer with folate. |
|
|
Jul 1, 2002 |
410 |
|
